{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T20:31:09Z","timestamp":1772915469549,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":6931,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2001]]},"DOI":"10.1093\/annonc\/12.suppl_2.s131","type":"journal-article","created":{"date-parts":[[2012,1,20]],"date-time":"2012-01-20T06:58:19Z","timestamp":1327042699000},"page":"S131-S134","source":"Crossref","is-referenced-by-count":22,"special_numbering":"S2","title":["Neuroendocrine tumors in the brain"],"prefix":"10.1016","volume":"12","author":[{"given":"P.","family":"Cavalla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Schiffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/12.suppl_2.S131_bb0010","series-title":"Endocrine Tumors","first-page":"531","article-title":"Neural crest tumors: Rationale for somatostatin and its analogs in diagnosis and therapy","author":"O\u2019Dorisio","year":"1993"},{"key":"10.1093\/annonc\/12.suppl_2.S131_bb0015","series-title":"The Role of Somatostatin: Basic and Clinical Aspects of Neuroscience Series","first-page":"1","article-title":"General aspect of the biology and function of somatostatin","author":"Patel","year":"1992"},{"key":"10.1093\/annonc\/12.suppl_2.S131_bb0020","first-page":"1","article-title":"Characterization of somatostatin receptors on human neuroblastoma tumors","volume":"5","author":"O\u2019Dorisio","year":"1994","journal-title":"Cell Growth Diff"},{"key":"10.1093\/annonc\/12.suppl_2.S131_bb0025","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1749-6632.1998.tb11208.x","article-title":"Neuropeptides in developmental tumors of the central and peripheral nervous system","volume":"865","author":"Fr\u00fchwald","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1093\/annonc\/12.suppl_2.S131_bb0030","series-title":"Tumours of the nervous system. Pathology and genetics","article-title":"WHO Classification of tumours","author":"Kleihues","year":"2000"},{"key":"10.1093\/annonc\/12.suppl_2.S131_bb0035","first-page":"1869","article-title":"Revision of the WHO classification of brain tumors for pediatric brain tumors","volume":"56","author":"Rorke","year":"1985","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1093\/annonc\/12.suppl_2.S131_bb0040","first-page":"498","article-title":"Primitive neuroectodermal tumors of the central nervous system","volume":"62","author":"Gould","year":"1990","journal-title":"Lab Invest"},{"key":"10.1093\/annonc\/12.suppl_2.S131_bb0045","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1203\/00006450-199905010-00016","article-title":"High expression of somatostatin receptor subtype 2 (sst2) in medulloblastoma: Implications for diagnosis and therapy","volume":"48","author":"Fr\u00fchwald","year":"1999","journal-title":"Ped Res"},{"key":"10.1093\/annonc\/12.suppl_2.S131_bb0050","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1023\/A:1005961302340","article-title":"A possible role for somatostatin receptor scintigraphy in the follow-up of children with medulloblastoma (MB)","volume":"38","author":"M\u00fcller","year":"1998","journal-title":"J Neurooncol"},{"key":"10.1093\/annonc\/12.suppl_2.S131_bb0055","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/BF03350317","article-title":"Molecular pharmacology of somatostatin receptor subtypes","volume":"20","author":"Patel","year":"1997","journal-title":"J Endocr Invest"},{"key":"10.1093\/annonc\/12.suppl_2.S131_bb0060","first-page":"3455","article-title":"Expression and localization of somatostatin receptor SSTR1, SSTR2 and SSSTR3 messenger RNA in primary human tumors using in situ hybridization","volume":"54","author":"Reubi","year":"1994","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/12.suppl_2.S131_bb0065","first-page":"1865","article-title":"Imrnunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A","volume":"6","author":"Schulz","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/12.suppl_2.S131_bb0070","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF01476412","article-title":"High sensitivity of the in vivo detection of somatostatin receptors by 111-indium (DTPA-octreotide)-scintigraphy in meningioma patients","volume":"126","author":"Hildebrandt","year":"1994","journal-title":"Acta Neurochir"},{"key":"10.1093\/annonc\/12.suppl_2.S131_bb0075","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/00006231-199509000-00006","article-title":"Somatostatin receptor imaging in CNS tumors using 111-In-octreotide","volume":"16","author":"Maini","year":"1995","journal-title":"Nucl Med Commun"},{"key":"10.1093\/annonc\/12.suppl_2.S131_bb0080","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/00006231-199604000-00157","article-title":"Somatostatin receptor scintigraphy in the differential diagnosis of meningioma","volume":"17","author":"Bohuslavizki","year":"1996","journal-title":"Nucl Med Commun"},{"key":"10.1093\/annonc\/12.suppl_2.S131_bb0085","first-page":"543","article-title":"Somatostatin inhibits the activity of adenilate cyclase cultured human meningioma cells and stimulates their growth","volume":"74","author":"Koper","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1093\/annonc\/12.suppl_2.S131_bb0090","first-page":"5758","article-title":"Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system","volume":"47","author":"Reubi","year":"1987","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/12.suppl_2.S131_bb0095","first-page":"403","article-title":"Somatostatin receptor scintigraphy in CNS tumors: Role of the blood brain barrier permeability","volume":"36","author":"Haldelmann","year":"1995","journal-title":"J Nucl Med"},{"key":"10.1093\/annonc\/12.suppl_2.S131_bb0100","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/BF01808548","article-title":"Scheidhauer K et al. 111Indium (DTPA)-octerotide scintigraphy in patients with cerebral gliomas","volume":"127","author":"Luyken","year":"1994","journal-title":"Acta Neurochir"},{"key":"10.1093\/annonc\/12.suppl_2.S131_bb0105","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1023\/A:1005893223090","article-title":"Somatostatin and somatostatin receptors in the diagnosis and treatment of gliomas","volume":"35","author":"Lamzus","year":"1997","journal-title":"J Neurooncol"},{"key":"10.1093\/annonc\/12.suppl_2.S131_bb0110","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1046\/j.1471-4159.1995.65051997.x","article-title":"Expression of somatostatin receptor subtypes in cultured astrocytes and gliomas","volume":"65","author":"Feindt","year":"1995","journal-title":"J Neurochem"},{"key":"10.1093\/annonc\/12.suppl_2.S131_bb0115","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0169-328X(98)00312-X","article-title":"Molecular analysis of the somatostatin receptor subtype 2 in human glioma cells","volume":"64","author":"Feindt","year":"1999","journal-title":"Mol Brain Res"},{"key":"10.1093\/annonc\/12.suppl_2.S131_bb0120","first-page":"1025","article-title":"Loco-regional regulatory peptide receptor targeting with the diffusible somatostatin analogue 90Y-labeled DOTA0-D-Phel-Tyr3-octerotide (DOTATOC): A pilot study in human gliomas","volume":"5","author":"Merlo","year":"1999","journal-title":"Clin Cancer Res"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419544830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419544830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/12\/suppl_2\/S131\/787107\/12-suppl_2-S131.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T15:58:15Z","timestamp":1589471895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419544830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001]]},"references-count":23,"alternative-id":["S0923753419544830"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/12.suppl_2.s131","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2001]]}}}